Study identifies miRNAs upregulated in SMA

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Jun 15 / Springer Healthcare

Study identifies miRNAs upregulated in SMA

Neuroscience Spinal Muscular Atrophy CURE-SMA-2022

Description

Emanuela Abiusi outlines the results of a study showing that certain microRNAs are upregulated in muscle biopsy and serum samples taken from people with spinal muscular atrophy, and discusses the potential of these microRNAs as a target for SMN-independent therapies.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.